BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Gastrointestinal Stromal Tumor Market: Increasing Prevalence of Genetic Disorders to Drive the Market

  Gastrointestinal stromal tumor is considered as one of the most common mesenchymal tumors across the globe.

  February 9, 2022

   · 

  5 min read
• Rising Need for Treatment of Biological Waste to Spur the Demand for Fluidized-Bed Bioreactors

  Fact.MR – A Market Research and Competitive Intelligence Provider: Between 2021 and 2031, the global fluidized-bed bioreactors market is expected to grow at a rapid pace.

  February 9, 2022

   · 

  6 min read
• Core One Labs’ Successful Patent Application Filing for Protection of its Biosynthetic Production System for Psilocybin Marks a Significant Milestone for the Progression of Psychedelic Health Care

  Core One Labs Inc. is pleased to announce that following its milestone announcement that its wholly-owned subsidiary, Vocan Biotechnologies Inc. ( Vocan ), has successfully engineered a novel recombinant production system for biologically synthesized (biosynthesized) psilocybin.

  February 9, 2022

   · 

  5 min read
• Genetown

  EdiGene and Neukio Enter Collaboration to Develop Next-Generation Immune Cell Therapies

  EdiGene, Inc. and Neukio Biotherapeutics announced an R&D collaboration to develop next-generation immune cell therapies.

  February 9, 2022

   · 

  3 min read
• Business

  Theravance Biopharma to Report Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022

  Theravance Biopharma, Inc. will report its fourth quarter and full year 2021 financial results and provide a business update after market close on Wednesday, February 23, 2022.

  February 9, 2022

   · 

  2 min read
• Opthea Announces Presentation at the Angiogenesis, Exudation, and Degeneration 2022 Conference

  Opthea Limited announced that an oral presentation will be presented at the Bascom Palmer Eye Institute Angiogenesis, Exudation, and Degeneration 2022 conference, taking place from February 11-12, 2022.

  February 9, 2022

   · 

  2 min read
• Biotech Beach

  ChromaDex Announces Issuance of New U.S. Continuation Patent, Expanding Intellectual Property Portfolio for Nicotinamide Riboside

  ChromaDex Corp. (NASDAQ:CDXC) today announced that it was granted a continuation patent, adding to its global patent portfolio surrounding nicotinamide riboside.

  February 9, 2022

   · 

  3 min read
• Business

  MagTrack Technology Opens Doors for Independent Operation of Smartphones, Computers, Other Devices for Wheelchair Users

  Brooks Rehabilitation is pleased to announce the MagTrack study, a collaborative research endeavor between Brooks and the Georgia Tech School of Electrical and Computer Engineering , has been successfully completed.

  February 9, 2022

   · 

  9 min read
• Genetown

  TCR² Therapeutics to Present at the SVB Leerink Global Healthcare Conference

  TCR 2 Therapeutics Inc. today announced that management will participate in a fireside chat at the 11th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 16 at 1:40PM E.T. using a virtual platform.

  February 9, 2022

   · 

  1 min read
• Business

  MEK Inhibitors Market Size Drugs Sales Forecast Clinical Trials Research Companies Report 2026MEK Inhibitors Drugs Sales Opportunity Expected To Surpass USD 3 Billion By 2026 Says Kuick Research

  MEK Inhibitors Market Size Drugs Sales Forecast Clinical Trials Research Companies Report 2026MEK Inhibitors Drugs Sales Opportunity Expected To Surpass USD 3 Billion By 2026 Says Kuick Research.

  February 9, 2022

   · 

  3 min read